Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover
CH Cheng, LR Chen, KH Chen - International journal of molecular …, 2022 - mdpi.com
Osteoporosis is a serious health issue among aging postmenopausal women. The majority
of postmenopausal women with osteoporosis have bone loss related to estrogen deficiency …
of postmenopausal women with osteoporosis have bone loss related to estrogen deficiency …
Antioxidant, anti-inflammatory, anti-menopausal, and anti-cancer effects of lignans and their metabolites
Since chronic inflammation can be seen in severe, long-lasting diseases such as cancer,
there is a high demand for effective methods to modulate inflammatory responses. Among …
there is a high demand for effective methods to modulate inflammatory responses. Among …
RANKL biology
N Takegahara, H Kim, Y Choi - Bone, 2022 - Elsevier
Since the receptor activator of nuclear factor-kappa B ligand (RANKL), its cognate receptor
activator of nuclear factor-kappa B (RANK), and the decoy receptor osteoprotegerin (OPG) …
activator of nuclear factor-kappa B (RANK), and the decoy receptor osteoprotegerin (OPG) …
Impact of the host response and osteoblast lineage cells on periodontal disease
M Zhou, DT Graves - Frontiers in immunology, 2022 - frontiersin.org
Periodontitis involves the loss of connective tissue attachment and alveolar bone. Single cell
RNA-seq experiments have provided new insight into how resident cells and infiltrating …
RNA-seq experiments have provided new insight into how resident cells and infiltrating …
Role of NF-κB in ageing and age-related diseases: lessons from genetically modified mouse models
VA García-García, JP Alameda, A Page, ML Casanova - Cells, 2021 - mdpi.com
Ageing is a complex process, induced by multifaceted interaction of genetic, epigenetic, and
environmental factors. It is manifested by a decline in the physiological functions of …
environmental factors. It is manifested by a decline in the physiological functions of …
Inflammation and epigenetic regulation in osteoarthritis
Osteoarthritis (OA) was once defined as a non-inflammatory arthropathy, but it is now well-
recognized that there is a major inflammatory component to this disease. In addition to …
recognized that there is a major inflammatory component to this disease. In addition to …
Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response
V Kostenko, O Akimov, O Gutnik, H Kostenko… - Heliyon, 2023 - cell.com
One of the adverse outcomes of acute inflammatory response is progressing to the chronic
stage or transforming into an aggressive process, which can develop rapidly and result in …
stage or transforming into an aggressive process, which can develop rapidly and result in …
ER stress, the unfolded protein response and osteoclastogenesis: a review
W Huang, Y Gong, L Yan - Biomolecules, 2023 - mdpi.com
Endoplasmic reticulum (ER) stress and its adaptive mechanism, the unfolded protein
response (UPR), are triggered by the accumulation of unfolded and misfolded proteins …
response (UPR), are triggered by the accumulation of unfolded and misfolded proteins …
Estrogen deficiency–mediated M2 macrophage osteoclastogenesis contributes to M1/M2 ratio alteration in ovariectomized osteoporotic mice
C Dou, N Ding, C Zhao, T Hou, F Kang… - Journal of Bone and …, 2018 - academic.oup.com
In this study, for the first time we discovered that the M1/M2 macrophage phenotype ratio is
increased in bone marrow of ovariectomized (OVX) osteoporotic C57BL/6 mice. Considering …
increased in bone marrow of ovariectomized (OVX) osteoporotic C57BL/6 mice. Considering …
[HTML][HTML] Osteoblastic and anti-osteoclastic activities of strontium-substituted silicocarnotite ceramics: In vitro and in vivo studies
J Zeng, J Guo, Z Sun, F Deng, C Ning, Y Xie - Bioactive materials, 2020 - Elsevier
Osteoporosis bone defect is a refractory orthopaedic disease which characterized by
impaired bone quality and bone regeneration capacity. Current therapies, including …
impaired bone quality and bone regeneration capacity. Current therapies, including …